Mauricio Lema

933 total citations
24 papers, 247 citations indexed

About

Mauricio Lema is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Mauricio Lema has authored 24 papers receiving a total of 247 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 8 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Mauricio Lema's work include BRCA gene mutations in cancer (4 papers), Breast Cancer Treatment Studies (4 papers) and Cancer Genomics and Diagnostics (4 papers). Mauricio Lema is often cited by papers focused on BRCA gene mutations in cancer (4 papers), Breast Cancer Treatment Studies (4 papers) and Cancer Genomics and Diagnostics (4 papers). Mauricio Lema collaborates with scholars based in Colombia, United States and Argentina. Mauricio Lema's co-authors include Thomas C. Sist, Akiko Okifuji, D. Turk, Michael A. Zevon, Patricia Harrison, Michael H. Miner, Song Li, Juan David Figueroa, M Llacuachaqui and Robert E. Royer and has published in prestigious journals such as Journal of Clinical Oncology, The Lancet Oncology and Pain.

In The Last Decade

Mauricio Lema

18 papers receiving 236 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mauricio Lema Colombia 8 69 63 60 53 44 24 247
Mathias Kvist Mejdahl Denmark 8 150 2.2× 32 0.5× 122 2.0× 45 0.8× 7 0.2× 11 347
Anthony F. Kirkpatrick United States 10 8 0.1× 49 0.8× 82 1.4× 63 1.2× 45 1.0× 19 263
Xiaodan Niu China 9 53 0.8× 9 0.1× 13 0.2× 88 1.7× 13 0.3× 12 349
Andreas Schwarzer Germany 11 86 1.2× 78 1.2× 99 1.6× 72 1.4× 2 0.0× 36 375
R. Alten Germany 6 23 0.3× 60 1.0× 10 0.2× 27 0.5× 6 0.1× 19 259
Sayaka Ogawa Japan 10 65 0.9× 9 0.1× 4 0.1× 50 0.9× 28 0.6× 34 341
Kimberly Levenhagen United States 6 264 3.8× 24 0.4× 52 0.9× 40 0.8× 2 0.0× 13 348
Woraluk Somboonporn Thailand 10 45 0.7× 8 0.1× 5 0.1× 13 0.2× 101 2.3× 23 336
Sarah Baker Canada 8 28 0.4× 84 1.3× 8 0.1× 16 0.3× 6 0.1× 30 246
Johannes Achenbach Germany 9 15 0.2× 20 0.3× 4 0.1× 30 0.6× 53 1.2× 21 405

Countries citing papers authored by Mauricio Lema

Since Specialization
Citations

This map shows the geographic impact of Mauricio Lema's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mauricio Lema with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mauricio Lema more than expected).

Fields of papers citing papers by Mauricio Lema

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mauricio Lema. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mauricio Lema. The network helps show where Mauricio Lema may publish in the future.

Co-authorship network of co-authors of Mauricio Lema

This figure shows the co-authorship network connecting the top 25 collaborators of Mauricio Lema. A scholar is included among the top collaborators of Mauricio Lema based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mauricio Lema. Mauricio Lema is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Contreras, F., Guillermo Sánchez, Pedro Ramos, et al.. (2023). Clinical Outcomes and Prognostic Factors of Patients With Early Malignant Melanoma in One Latin American Country: Results of the Epidemiological Registry of Malignant Melanoma in Colombia Study. JCO Global Oncology. 9(9). e2200377–e2200377. 1 indexed citations
4.
Preciado, Beatriz, et al.. (2023). The first report of institutional cancer registry in a center located in Medellín, Colombia. 10(1). 27–42. 1 indexed citations
5.
6.
7.
Sanabria‐Salas, María Carolina, et al.. (2021). NGS in Lung, Breast, and Unknown Primary Cancer in Colombia: A Multidisciplinary Consensus on Challenges and Opportunities. JCO Global Oncology. 7(7). 1012–1023. 12 indexed citations
8.
Lema, Mauricio, et al.. (2021). Concordance between 21-gene score (Oncotype DX) and clinical-pathologic prognostic models in early-breast cancer in Medellín, Colombia.. Journal of Clinical Oncology. 39(15_suppl). e12521–e12521.
9.
Gómez, Henry, Enrique Bargalló‐Rocha, C Allemand, et al.. (2021). Practice-Changing Use of the 21-Gene Test for the Management of Patients With Early-Stage Breast Cancer in Latin America. JCO Global Oncology. 7(7). 1364–1373. 4 indexed citations
10.
11.
Lema, Mauricio. (2020). Viruela: el monstruo moteado. 42(2). 211–221.
12.
Guindalini, Rodrigo Santa Cruz, Andrea S. Llera, Bettina Müller, et al.. (2019). Personalizing Precision Oncology Clinical Trials in Latin America: An Expert Panel on Challenges and Opportunities. The Oncologist. 24(8). e709–e719. 12 indexed citations
13.
Muniz, David Queiroz Borges, Hongbo Yang, James Signorovitch, et al.. (2019). Real-World Effectiveness and Tolerability of Pazopanib as First Targeted Therapy in Metastatic Renal Cell Carcinoma: A Retrospective Chart Review in Latin America. Advances in Therapy. 36(12). 3446–3457. 2 indexed citations
14.
Martín, Claudio, Andrés F. Cardona, Zyanya Lucía Zatarain-Barrón, et al.. (2018). Real-World Treatment Patterns, Survival, and Prediction of CNS Progression in ALK-Positive Non-Small-Cell Lung Cancer Patients Treated with First-Line Crizotinib in Latin America Oncology Practices. Oncology. 94(5). 297–305. 7 indexed citations
15.
Llacuachaqui, M, Juan David Figueroa, Jorge Madrid, et al.. (2014). Prevalence of BRCA1 and BRCA2 mutations in unselected breast cancer patients from Medellín, Colombia. Hereditary Cancer in Clinical Practice. 12(1). 11–11. 41 indexed citations
16.
Lema, Mauricio, et al.. (2011). Neumonía por Legionella en pacientes con leucemia. Presentación de dos casos. 25(2). 213–220.
17.
Lamas, María Jesús, et al.. (2010). Retrospective epidemiologic study to evaluate the pattern of use of biphosphonates in the treatment of bone metastasis in solid tumor cancer patients (REBIUS).. Journal of Clinical Oncology. 28(15_suppl). e19667–e19667. 1 indexed citations
18.
Prieto, José M., et al.. (2001). Pentoxifilina: ¿es útil en la esclerosis múltiple ?. Revista de Neurología. 32(6). 529–529. 1 indexed citations
19.
Turk, D., Thomas C. Sist, Akiko Okifuji, et al.. (1998). Adaptation to metastatic cancer pain, regional/local cancer pain and non-cancer pain: role of psychological and behavioral factors. Pain. 74(2). 247–256. 105 indexed citations
20.
Sist, Thomas C., et al.. (1997). Experience with gabapentin for neuropathic pain in the head and neck: Report of ten cases. Regional Anesthesia & Pain Medicine. 22(5). 473–478. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mathias Kvist Mejdahl Breakdown of academic impact, for papers by Anthony F. Kirkpatrick Breakdown of academic impact, for papers by Xiaodan Niu Breakdown of academic impact, for papers by Andreas Schwarzer Breakdown of academic impact, for papers by R. Alten Breakdown of academic impact, for papers by Sayaka Ogawa Breakdown of academic impact, for papers by Kimberly Levenhagen Breakdown of academic impact, for papers by Woraluk Somboonporn Breakdown of academic impact, for papers by Sarah Baker Breakdown of academic impact, for papers by Johannes Achenbach
Rankless by CCL
2026